Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Australia and New Zealand In Vitro Diagnostics Market Outlook

The Australia and New Zealand in vitro diagnostics market size is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, driven by rising technical advancements to develop new diagnostic tools along with increasing expenditures and investments in the healthcare domain across the region.

Australia and New Zealand In Vitro Diagnostics Market Overview

The in vitro diagnostics market in Australia and New Zealand has witnessed significant growth driven owing to factors like advancements in diagnostic techniques and increasing adoption of molecular diagnostics, point of care testing and digital technologies to offer early detection and prevention of diseases. In 2023, around 154,000 new cancer cases  are expected to be diagnosed in the Australian population. As in vitro diagnostics find its application in cancer detection, the Australia and New Zealand in vitro diagnostics market demand is predicted to grow in the coming years.

The market is further driven by the increased government efforts to offer awareness on early diagnosis and preventive healthcare. The region has been witnessing a significant surge in investments to improve and upgrade the diagnostic facilities as well.

Surge in Research and Development Activities to Develop New Diagnostic Devices

In September 2023,  the scientists of Peter Doherty Institute for Infection and Immunity (Doherty Institute) and WEHI (Walter and Eliza Hall Institute of Medical Research) developed MPXV-CRISPR, the first CRISPR based diagnostic tool to detect monkeypox virus (MPXV) in clinical samples. Leveraging the extremely sensitive and powerful technology, the diagnostic tool is designed to target genetic sequences present exclusively in MPXV. The advent of the novel tool can be a breakthrough to help in monkey pox infection detection and treatment as the conventional lab tests take multiple days to provide results. The increasing emphasis on preventing the spread of infectious diseases, especially after the sudden outbreak of COVID-19 is anticipated to bolster the Australia and New Zealand in vitro diagnostics market growth in upcoming years.

Growth in Government Investments

In June 2023, the Australian Government granted USD 73 million  to upgrade and implement new medical technologies across the region. The investment was divided into 19 different projects wherein, around USD 9.8 million was aimed at offering cancer treatment with the Targeted Alpha Therapy and around USD 2.9 million was set aside to support Australia’s first human microbiome bank. The investment is poised to help the scientists with research and development to develop better solutions for fatal diseases. In addition, increased investments from private ventures and other entities are also expected to increase the Australia and New Zealand in vitro diagnostics market size.

Rising Prevalence for Remote Test Kits

In July 2023, Trajan Scientific and Medical registered a collection of Neoteryx’s  remote micro sampling devices and test kits. Mitra® has been classified as Class I in vitro diagnostic (IVD) medical device by the Therapeutic Goods Administration (TGA) in Australia while Mitra® Sample Collection Kit has been titled as a Class IIa medical device for home use. Contributing to the emerging trend of telehealth and remote monitoring, the devices are expected to boost the Australia and New Zealand in vitro diagnostics market share by offering personalized solutions to the patients. The devices offer self-guided specimen collection, owing to its easy to use and finger stick method. Specimens collected through the devices have been used to examine antibodies against SARS-CoV-2, inflammatory biomarkers, PSA for prostate cancer screenings, and more.

Australia and New Zealand In Vitro Diagnostics Market Segmentation

Market Breakup by Technology

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immuno Diagnostics
  • Hematology
  • Others

Market Breakup by Product and Services

  • Instruments
  • Reagents and Kits
  • Services
  • Data Management Software

Market Breakup by Applications

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Other Applications

Market Breakup by End User

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Academic Institutes
  • Point-of-Care Testing centers
  • Others

Market Breakup by Country

  • Australia
  • New Zealand

Australia and New Zealand In Vitro Diagnostics Market Regional Analysis

In the forecast period, Australia is expected to lead the market for in vitro diagnostics, which can be attributed to the rising investments in the healthcare medical infrastructure. In March 2023, researchers from the University of Sydney were awarded USD 47 million  to support their investigations on younger onset-dementia and treatment of blinding eye diseases through stem cell therapies. The Government of Australia also presented their support for enhanced research activities by launching the Medical Research Future Fund (MRFF) grant.

With the rising prevalence of geriatric population and a surge in budding technology driven start-ups, the market is likely to witness further growth.

New Zealand is also predicted to witness significant growth. In December 2022, Pictor, a New Zealand based start-up, expanded their product pipeline to apply cost effective, accurate, and prompt testing services for diseases by deploying multiple innovative approaches. The start-up raised USD 5 million and successfully launched PictArray SARS-CoV-2 IgG Antibody  Test.

Australia and New Zealand In Vitro Diagnostics Market: Competitor Landscape

In December 2023, the Bridgewest Group  announced their expansion of biomedical operations in Bentley, Perth with the help of USD 2 million investment from the Western Australian Government. The expansion is aimed at boosting local manufacturing of several medical products along with the installation of new automated blow, fill, and seal line of products. Apart from boosting the infrastructure and facilities, the initiative is expected to offer 400 jobs to the local community, boosting the overall economy as well. The market has been experiencing similar investment initiatives and partnerships to enhance the quality of solutions and facilities being offered to the patients.

The key features of the Australia and New Zealand in vitro diagnostics market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • BioMerieux SA
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Roche Diagnostics
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Quidel Corporation
  • Diasorin S.P.A
  • Illumina, Inc.
  • Hologic, Inc

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Product and Services
  • Applications
  • End User
  • Region
Breakup by Technology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Immuno Diagnostics
  • Hematology
  • Others
Breakup by Product and Services
  • Instruments
  • Reagents and Kits
  • Services
  • Data Management Software
Breakup by Applications
  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Other Applications
Breakup by End User
  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Academic Institutes
  • Point-of-Care Testing centers
  • Others
Breakup by Region
  • Australia
  • New Zealand
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • BioMerieux SA
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Abbott Laboratories, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Roche Diagnostics
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Quidel Corporation
  • Diasorin S.P.A
  • Illumina, Inc.
  • Hologic, Inc

Australia and New Zealand In Vitro Diagnostics Market Report Snapshots

Australia and New Zealand In Vitro Diagnostics Market Size

Australia and New Zealand In Vitro Diagnostics Regional Analysis

Australia and New Zealand In Vitro Diagnostics Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 5.4% during the forecast period of 2024-2032, likely to be driven by increasing technical advancements to develop new diagnostic tools along with growing expenditures and government investments in the healthcare domain across the region.

The market demand is driven by the rising prevalence of chronic diseases in the region, owing to an aging population along with rising emphasis on improving the medical research infrastructure.

The growing advancements in upgrading and launching new research facilities is a major market trend. In September 2023, the Australian scientists developed MPXV-CRISPR, the first CRISPR based diagnostic tool to detect monkeypox virus (MPXV) in clinical samples.

Based on technology, the market is divided into clinical chemistry, molecular diagnostics, immuno diagnostics, and hematology, among others.

Major end users include diagnostic laboratories, hospitals and clinics, academic institutes, and point-of-care testing centres, among others.

Instruments, reagents and kits, services, and data management software are common products and services available in the market.

Common application areas include infectious disease, diabetes, cancer/oncology, cardiology, and autoimmune disease, among others.

Based on countries, it includes Australia and New Zealand.

Key players involved in the market are BioMerieux SA., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Abbott Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., QIAGEN N.V., Roche Diagnostics, Danaher Corporation, Agilent Technologies, Inc., Diasorin S.P.A, Illumina, Inc., Hologic, Inc., and Quidel Corporation.

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,869

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,799

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124